Sur la page PubMed vous trouverez la plupart des publications. Cette sélection n'est pas exhaustive.

​

• NEW " 2p25.3 microduplications involving MYT1L: further phenotypic characterization through an assessment of 16 new cases and a literature review", Malek Bouassida et al - European Journal of Human Genetics, published on line : may 15, 2023

​​

• NEW "MYT1L is required for suppressing earlier neuronal development programs in the adult mouse brain", Jiayang Chen et al - Genome Research, published on line : April 26, 2023

​​

• NEW "MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention", Moritz Mall et al - Molecular Psychiatry, Nature, published on line : 14 february 2023

​​

• NEW "MYT1L in the making: emerging insights on functions of a neurodevelopmental disorder gene"

Jiayang Chen, Allen Yen , Colin P. Florian and Joseph D. Dougherty, Translational Psychiatry (www.nature.com), 2022

​

• NEW "Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice"

Markus Wöhr, Wendy M. Fong6, Justyna A. Janas6, Moritz Mall6, Christian Thome6 , Madhuri Vangipuram6 , Lingjun Meng6, Thomas C. Südhof and Marius Wernig6, Molecular Autism, 2022

​

• Article de presse : "Cluster of traits tied to rare mutations in autism-linked gene", by Anna Goshua,  20/12/ 2021, Spectrum

​​

• Article de presse "Jake’s mice: Searching for answers to the puzzle of autism", by Laura Unga, January 2, 2022

 

• Article de commentaire :  Unraveling the mysteries of MYT1L: From reprogramming factor to multifaceted regulator of neuronal differentiation

Aniket Bhattacharya and M. Chiara Manzini, décembre 2021, Neuron

​

• A MYT1L Syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation

Jiayang Chen et al, décembre 2021, Neuron 

​

• 📍Trouble neurodéveloppemental associé à MYT1L : description de 40 nouveaux cas et revue de la littérature sur les aspects cliniques et moléculaires

A.M. Guerrot, J. Coursimault, F. Lecoquierre et al, novembre 2021, Human Genetics

​

• Neuf individus nouvellement identifiés affinent le phénotype associé aux mutations MYT1L

Isabelle C Windheuser et al, February 2020, American Journal of Medical Genetics

​

• MYT1L mutations cause intellectual disability and variable obesity by dysregulating gene expression and development of the neuroendocrine hypothalamus

Blanchet et al., 2017, Plos Genetics

​

• Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity"

Nina De Rocker et al, June 2015, Genetics in Medicine

​

•   A new patient with a terminal de novo 2p25.3 deletion of 1.9 Mb associated with early-onset of obesity, intellectual disabilities and hyperkinetic disorder

Maria Clara Bonaglia, Roberto Giorda and Sergio Zanini, 2014, Molecular Cytogenetics

​

• Direct conversion of fibroblasts to functional neurons by defined factors

Thomas Vierbuchen et al, 2010, Nature

​

• Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system

Kim et al, 1997, Neuroscience Research

​

• 📍 Novel member of the zinc finger superfamily: a C(2)-HC finger that recognizes a glia-specific gene

Kim, J. G., Hudson, L. D, 1992, Medical Genetics